BG43865A3 - Method for preparing of 1, 3- disubstituted 2- oxyindols - Google Patents
Method for preparing of 1, 3- disubstituted 2- oxyindolsInfo
- Publication number
- BG43865A3 BG43865A3 BG072172A BG7217285A BG43865A3 BG 43865 A3 BG43865 A3 BG 43865A3 BG 072172 A BG072172 A BG 072172A BG 7217285 A BG7217285 A BG 7217285A BG 43865 A3 BG43865 A3 BG 43865A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- disubstituted
- new
- oxyindols
- analgesic
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- -1 1,3-disubstituted 2-oxindoles Chemical class 0.000 abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57790384A | 1984-02-07 | 1984-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG43865A3 true BG43865A3 (en) | 1988-08-15 |
Family
ID=24310612
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG072172A BG43865A3 (en) | 1984-02-07 | 1985-02-06 | Method for preparing of 1, 3- disubstituted 2- oxyindols |
| BG072170A BG44204A3 (en) | 1984-02-07 | 1985-02-06 | Method for preparing of 2- oxyindol derivatives |
| BG068717A BG40963A3 (en) | 1984-02-07 | 1985-02-06 | Method for preparing 1, 3- disubstituted 2- oxyindols |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG072170A BG44204A3 (en) | 1984-02-07 | 1985-02-06 | Method for preparing of 2- oxyindol derivatives |
| BG068717A BG40963A3 (en) | 1984-02-07 | 1985-02-06 | Method for preparing 1, 3- disubstituted 2- oxyindols |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4658037A (enExample) |
| JP (1) | JPS60248669A (enExample) |
| KR (2) | KR880000433B1 (enExample) |
| BG (3) | BG43865A3 (enExample) |
| CS (1) | CS252480B2 (enExample) |
| DD (2) | DD234417A5 (enExample) |
| HU (1) | HU194166B (enExample) |
| IN (1) | IN163263B (enExample) |
| MW (1) | MW185A1 (enExample) |
| PL (3) | PL145310B1 (enExample) |
| RO (2) | RO93218B (enExample) |
| YU (3) | YU43866B (enExample) |
| ZA (1) | ZA85888B (enExample) |
| ZM (1) | ZM785A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721712A (en) * | 1984-06-12 | 1988-01-26 | Pfizer Inc. | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents |
| US4808601A (en) * | 1984-09-19 | 1989-02-28 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| HU215112B (hu) * | 1989-01-10 | 1998-12-28 | Pfizer Inc. | Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására |
| US4952703A (en) * | 1989-05-25 | 1990-08-28 | Pfizer Inc. | Intermediates for making 2-oxindole-1-carboxamides |
| US5086186A (en) * | 1989-05-25 | 1992-02-04 | Pfizer Inc. | N-trichloroacetyl-2-oxindole-1-carboxamides |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6919211B1 (en) | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
| US6955915B2 (en) | 1989-06-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus comprising polymers |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| DE69305999T2 (de) * | 1993-02-09 | 1997-03-06 | Pfizer Inc., New York, N.Y. | Oxindol 1-[n-(alkoxycarbonyl)]carboxamide und 1-[n-carboxamido]carboxamide als antiinflammatorische wirkstoffe |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| JP2009040790A (ja) * | 2008-08-29 | 2009-02-26 | Ube Ind Ltd | ５−フルオロオキシインドールの製造法 |
| US20110305751A1 (en) | 2009-02-20 | 2011-12-15 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| AU2010245823B2 (en) | 2009-05-06 | 2016-11-24 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| CN103570604B (zh) * | 2012-07-21 | 2015-10-07 | 重庆圣华曦药业股份有限公司 | 齐拉西酮中间体的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3462450A (en) * | 1966-06-29 | 1969-08-19 | Merck & Co Inc | Chemical compounds |
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| US3519592A (en) * | 1967-04-18 | 1970-07-07 | Smithkline Corp | Indole compounds |
| US3631177A (en) * | 1967-04-18 | 1971-12-28 | Smith Kline French Lab | 3-phenacyl-2-oxoindolines |
| BE714717A (enExample) * | 1967-05-12 | 1968-09-30 | ||
| FR7337M (enExample) * | 1968-01-11 | 1969-10-13 | ||
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
-
1985
- 1985-01-22 IN IN42/DEL/85A patent/IN163263B/en unknown
- 1985-02-04 RO RO121802A patent/RO93218B/ro unknown
- 1985-02-04 RO RO85117533A patent/RO90621A2/ro unknown
- 1985-02-05 ZM ZM7/85A patent/ZM785A1/xx unknown
- 1985-02-05 KR KR1019850000714A patent/KR880000433B1/ko not_active Expired
- 1985-02-05 MW MW1/85A patent/MW185A1/xx unknown
- 1985-02-05 CS CS85785A patent/CS252480B2/cs unknown
- 1985-02-06 BG BG072172A patent/BG43865A3/xx unknown
- 1985-02-06 YU YU180/85A patent/YU43866B/xx unknown
- 1985-02-06 BG BG072170A patent/BG44204A3/xx unknown
- 1985-02-06 JP JP60020163A patent/JPS60248669A/ja active Granted
- 1985-02-06 HU HU854686A patent/HU194166B/hu unknown
- 1985-02-06 DD DD85273087A patent/DD234417A5/de not_active IP Right Cessation
- 1985-02-06 BG BG068717A patent/BG40963A3/xx unknown
- 1985-02-06 ZA ZA85888A patent/ZA85888B/xx unknown
- 1985-02-07 PL PL1985255465A patent/PL145310B1/pl unknown
- 1985-02-07 PL PL1985251869A patent/PL145196B1/pl unknown
- 1985-02-07 PL PL1985255466A patent/PL145230B1/pl unknown
- 1985-12-30 US US06/814,719 patent/US4658037A/en not_active Expired - Lifetime
-
1986
- 1986-04-01 DD DD86288635A patent/DD244133A5/de not_active IP Right Cessation
-
1987
- 1987-04-10 KR KR1019870003430A patent/KR880000434B1/ko not_active Expired
- 1987-07-09 YU YU129087A patent/YU46320B/sh unknown
- 1987-10-30 YU YU1981/87A patent/YU44062B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU18085A (en) | 1988-04-30 |
| PL255465A1 (en) | 1986-07-15 |
| MW185A1 (en) | 1986-04-09 |
| CS78585A2 (en) | 1987-01-15 |
| HU194166B (en) | 1988-01-28 |
| RO90621A2 (ro) | 1986-12-10 |
| YU198187A (en) | 1988-10-31 |
| PL145196B1 (en) | 1988-08-31 |
| JPS60248669A (ja) | 1985-12-09 |
| PL145310B1 (en) | 1988-09-30 |
| YU44062B (en) | 1990-02-28 |
| US4658037A (en) | 1987-04-14 |
| DD244133A5 (de) | 1987-03-25 |
| PL251869A1 (en) | 1985-12-17 |
| YU129087A (en) | 1988-02-29 |
| BG44204A3 (en) | 1988-10-14 |
| KR880000433B1 (ko) | 1988-03-24 |
| CS252480B2 (en) | 1987-09-17 |
| KR880000434B1 (ko) | 1988-03-24 |
| YU46320B (sh) | 1993-05-28 |
| KR850005824A (ko) | 1985-09-26 |
| RO93218B (ro) | 1988-01-01 |
| IN163263B (enExample) | 1988-08-27 |
| DD234417A5 (de) | 1986-04-02 |
| ZA85888B (en) | 1986-09-24 |
| PL145230B1 (en) | 1988-08-31 |
| JPH0413340B2 (enExample) | 1992-03-09 |
| YU43866B (en) | 1989-12-31 |
| RO93218A (ro) | 1987-12-31 |
| BG40963A3 (en) | 1987-03-14 |
| ZM785A1 (en) | 1985-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG43865A3 (en) | Method for preparing of 1, 3- disubstituted 2- oxyindols | |
| NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
| RU95112575A (ru) | Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция | |
| SE8804036D0 (sv) | New use of 11,28-dioxa-4-azatricyclo(22.3.1.0?724,9 )octacos-18-ene derivatives and pharmaceutical compositions containing them | |
| EP0784429A4 (en) | Method and formulation of stimulating nitric oxide synthesis | |
| IE45439L (en) | Penicillanic acid derivatives | |
| NO164166C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoletanolestere. | |
| NO167862C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat. | |
| PT89788A (pt) | Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem | |
| FR2407928A1 (fr) | Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation | |
| HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
| BG47648A3 (en) | Method for preparing of triazolyl quanolinic compounds | |
| NO900342L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)akridin-7-karboxylsyrer og beslektede forbindelser. | |
| IE44030L (en) | Ó-amino-ketones. | |
| ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
| IE51737B1 (en) | Topical formulations of 3-deazaadenosine | |
| MA20097A1 (fr) | Procede de preparation du diniflumate d'ester morpholineotylique d'acide niflumique utilise en therapeutique comme analgesique et anti-inflammatoire. | |
| DE2963010D1 (en) | 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture | |
| KR910019974A (ko) | 치환된 인돌 | |
| DE3766334D1 (de) | Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel. | |
| NO164243C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater | |
| FR2580648B1 (fr) | Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| AU1099888A (en) | Novel imidazo- and triazolothiadiazines, a process for the preparation thereof, medicaments containing same, and the use thereof, and some intermediates formed in the preparation of the compounds mentioned | |
| EP0202084A3 (en) | Fluoroalkane derivatives | |
| FI896228A0 (fi) | Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja |